SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001730463-24-000045
Filing Date
2024-03-21
Accepted
2024-03-21 16:21:30
Documents
14
Period of Report
2024-03-21
Items
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review

Document Format Files

Seq Description Document Type Size
1 8-K autl-20240321.htm   iXBRL 8-K 35256
  Complete submission text file 0001730463-24-000045.txt   190267

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT autl-20240321.xsd EX-101.SCH 2401
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT autl-20240321_def.xml EX-101.DEF 6172
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT autl-20240321_lab.xml EX-101.LAB 26747
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT autl-20240321_pre.xml EX-101.PRE 17256
18 EXTRACTED XBRL INSTANCE DOCUMENT autl-20240321_htm.xml XML 3974
Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38547 | Film No.: 24771674
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)